Dyslipidemia in Noninsulin-Dependent Diabetes Mellitus

  • Lisa A. Kosmiski
  • Robert H. Eckel
Chapter
Part of the Contemporary Biomedicine book series (CB, volume 15)

Abstract

Noninsulin dependent diabetes mellitus (NIDDM) is a common metabolic disorder familiar to most physicians. Its complications and associated conditions are numerous and require much attention from both caregivers and patients. On the surface, dyslipidemia in diabetes may seem relatively inconsequential to the wellbeing of these patients. However, the high prevalence of coronary artery disease (CAD) in the NIDDM population mandates careful attention to any factors that may play a role in its development. In our opinion, the lipoprotein alterations that accompany NIDDM play a major role in the development of coronary atherosclerosis, and so are indirectly an important cause of morbidity and mortality in the NIDDM population. Therefore, this chapter will focus primarily on the relationship between diabetic dyslipidemia and CAD.

Keywords

Glycemic Control Intensive Insulin Therapy NIDDM Patient Postprandial Lipemia Coronary Artery Disease Event 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Taskinen M. Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus. Diabetes 1992; 41: 12–17.PubMedCrossRefGoogle Scholar
  2. 2.
    Ingelfinger JA, Bennet PH, Liebow IM, Miller M. Coronary heart disease in the Pima Indians: electrocardiographic findings and postmortem evidence of myocardial infarction in a population with a high prevalence of diabetes mellitus. Diabetes 1976; 25: 561–565.PubMedCrossRefGoogle Scholar
  3. 3.
    Pyorala K. Diabetes and coronary artery disease: what a coincidence? J Cardiovasc Pharm 1990; 16: S8 - S14.Google Scholar
  4. 4.
    Garcia MJ, McNamara PM, Gordon T, Kannell WB. Morbidity and mortality in diabetics in the Framingham population. Diabetes 1974; 23: 105–111.PubMedGoogle Scholar
  5. 5.
    Fontbonne A. Relationship between diabetic dyslipoproteinemia and coronary heart disease risk in subjects with non-insulin-dependent diabetes. Diabetes/Metab Rev 1991; 7: 179–189.CrossRefGoogle Scholar
  6. 6.
    American Diabetes Association. Nutrition recommendations and principles for people with diabetes mellitus. Position statement. Diabetes Care 1994; 17: 519–522.CrossRefGoogle Scholar
  7. 7.
    Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care 1979; 2: 120–126.PubMedCrossRefGoogle Scholar
  8. 8.
    West KM, et al. The role of circulating glucose and triglyceride concentrations and their interactions with other “risk factors” as determinants of arterial disease in nine diabetic population samples from the WHO Multinational Study. Diabetes Care 1983; 6: 361–369.PubMedCrossRefGoogle Scholar
  9. 9.
    Winocour PD, Richardson M. thrombosis and atherogenesis in diabetes. In: Diabetes and Atherosclerosis. Draznin B, Eckel RH, eds. New York: Elsevier, 213–228, 1993.Google Scholar
  10. 10.
    Dunn FL. Management of hyperlipidemia in diabetes mellitus. Endocrinol Metab Clin North Am 1992; 21: 395–414.Google Scholar
  11. 11.
    Joven J, Costa B, Turner PR, Richart C, Masana L. Concentrations of lipids and apolipoproteins in patients with clinically well-controlled insulin-dependent and non-insulin-dependent diabetes. Clin Chem 1989; 35: 813–816.PubMedGoogle Scholar
  12. 12.
    Howard BV. Lipoprotein metabolism in diabetes. Curr Opinion Lipidology 1994; 5: 216–220.CrossRefGoogle Scholar
  13. 13.
    Garg A, Grundy SM. Management of dyslipidemia in NIDDM. Diabetes Care 1990; 13: 153–169.PubMedCrossRefGoogle Scholar
  14. 14.
    Syvanne M, Ahola M, Landenpera S, et al. High density lipoprotein subfractions in noninsulin-dependent diabetes mellitus and coronary artery disease. J Lipid Res 1995; 36: 573–582.PubMedGoogle Scholar
  15. 15.
    Harris MI. Hypercholesterolemia in individuals with diabetes and glucose intolerance in the U.S. population. Diabetes Care 1991; 14: 366–374.PubMedCrossRefGoogle Scholar
  16. 16.
    Stewart MW, Laker MF, Alberti KGMM. The contribution of lipids to coronary heart disease mellitus. J Int Med 1994; 236: 41–46.Google Scholar
  17. 17.
    Chen Y-DI, Swami S, Skowronski R, Coulston A, Reaven GM. Differences in postprandial lipemia between patients with normal glucose tolerance and noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1993; 76: 172–177.PubMedCrossRefGoogle Scholar
  18. 18.
    Lewis GF, O’Meara NM, Soltys PA, et al. Fasting hypertriglyceridemia in noninsulindependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities. J Clin Endocrinol Metab 1991; 72: 934–944.PubMedCrossRefGoogle Scholar
  19. 19.
    Haffner SM. Lipoprotein(a) and diabetes. Diabetes Care 1993; 16: 835–840.PubMedCrossRefGoogle Scholar
  20. 20.
    Velho G, Erlich D, Turpin E, et al. Lipoprotein (a) in diabetic patients and normoglycemic relatives in familial NIDDM. Diabetes Care 1993; 16: 742–747.PubMedCrossRefGoogle Scholar
  21. 21.
    NIH Consensus Conference: Triglyceride, high-density lipoprotein, and coronary heart disease. JAMA 1993; 269: 505–510.CrossRefGoogle Scholar
  22. 22.
    Fontbonne A, Eschwege E, Cambien F, et al. Hypertriglyceridemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes: results from the 11-year follow-up of the Paris Prospective Study. Diabetolgia 1989; 32: 300–304.CrossRefGoogle Scholar
  23. 23.
    Laakso M, Lehto S, Penttila I, Pyorala K. Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes. Circulation 1993; 88: 1421–1430.PubMedCrossRefGoogle Scholar
  24. 24.
    Laakso M, Ronnemaa T, Pyorala K, Kallio V, Puukka P, Penttila I. Atherosclerotic vascular disease and its risk factors in non-insulin-dependent diabetic and nondiabetic subjects in Finland. Diabetes Care 1988; 11: 449–463.PubMedCrossRefGoogle Scholar
  25. 25.
    Reckless JPD. Betteridge DJ, Wu P, Payne B, Galton DJ. High-density and low-density lipoproteins and prevalence of vascular disease in diabetes mellitus. Brit Med J 1978; 1: 883–886.PubMedCrossRefGoogle Scholar
  26. 26.
    Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: the Framingham Study. Circulation 1979; 58: 8–13.CrossRefGoogle Scholar
  27. 27.
    Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. Mortality from coronary heart disease and stroke in relation to degree of glycemia: the Whitehall study. Brit Med J 1983; 287: 867–870.Google Scholar
  28. 28.
    Stamler J, Vaccano O, Wentworth D, Newton J. Clinical diabetes and cardiovascular risks: 10 year mortality data on the 361,662 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT) [Abstract]. Circulation 1990; 81: 6.Google Scholar
  29. 29.
    Rosengren A, Welkt L, Tsipogianni A, Wilhelmsen L. Impact of cardiovascular risk factors on coronary heart disease and mortality among middle-aged diabetic men: a general population study. Br Med J 1989; 299: 1127–1131.CrossRefGoogle Scholar
  30. 30.
    Cavallero E, Dacheet C, Neufcour D, Wirquin E, Mathe D, Jacotot B. Postprandial amplification of lipoprotein abnormalities in controlled type II diabetic subjects: relationship to postprandial lipemia and C-peptide/glucagon levels. Metabolism 1994; 43: 270–278.PubMedCrossRefGoogle Scholar
  31. 31.
    Syvanne M, Hilden H, Taskinen M. Abnormal metabolism of postprandial lipoproteins in patients with non-insulin-dependent diabetes mellitus is not related to coronary artery disease. J Lipid Res 1994; 35: 15–26.PubMedGoogle Scholar
  32. 32.
    Haffner SM, Moss SE, Klein BEK, Klein R. Lack of association between lipoprotein(a) concentrations and coronary heart disease mortality in diabetes: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Metabolism 1992; 41: 194–197.CrossRefGoogle Scholar
  33. 33.
    Heller FR, Jamart J, Honore P, et al. Serum lipoprotein (a) in patients with diabetes mellitus. Diabetes Care 1993; 16: 819–823.PubMedCrossRefGoogle Scholar
  34. 34.
    Howard BV, Knowler WC, Vasquez B, Kennedy AL, Pettitt DJ, Bennett PH. Plasma and lipoprotein cholesterol and triglyceride in the Pima Indian population: comparison of diabetics and nondiabetics. Arteriosclerosis 1984; 4: 462–471.PubMedCrossRefGoogle Scholar
  35. 35.
    Aizawa T, Kobayashi M, Sato Y, et al. Possible link between a low prevalence of cardiovascular disease and mild dyslipidemia: a study in Japanese patients with type II diabetes. Diabetic Med 1992; 10: 431–437.CrossRefGoogle Scholar
  36. 36.
    Pan XR, Walden CE, Warrick GR, et al. Comparison of plasma lipoproteins and apoproteins in Chinese and American non-insulin-dependent diabetic subjects and controls. Diabetes Care 1986; 9: 395–400.PubMedCrossRefGoogle Scholar
  37. 37.
    Mattock MB, Keen H, Viberti GC, et al. Coronary heart disease and urinary albumin excretion rate in Type 2 diabetic patients. Diabetologia 1988; 31: 82–87.PubMedCrossRefGoogle Scholar
  38. 38.
    Billingham MS, Milles JJ, Bailey CJ, Hall RA. Lipoprotein subfraction composition in noninsulin-dependent diabetes treated by diet, sulphonylurea, and insulin. Metabolism 1989; 38: 850–857.PubMedCrossRefGoogle Scholar
  39. 39.
    Fielding CJ, Reavien GM, Fielding PE. Human non-insulin-dependent diabetes: identification of a defect in plasma cholesterol transport normalized in vivo by insulin and in vitro by selective immunoadsorption of apolipoprotein. Proc Natl Acad Sci USA 1982; 79: 6365–6369.PubMedCrossRefGoogle Scholar
  40. 40.
    Howard BV. Lipoprotein metabolism in diabetes mellitus. J Lipid Res 1987; 28: 613–628.PubMedGoogle Scholar
  41. 41.
    Imari Y, Koga S, Ibayashi H. Phenotypes of apolipoprotein E and abnormalities in lipid metabolism in patients with non-insulin-dependent diabetes mellitus. Metabolism 1988; 37: 1134–1138.Google Scholar
  42. 42.
    Shriver MD, Boerwinkle E, Hewwett-Emmett D, Hanis CL. Frequency and effects of apolipoprotein E polymorphism in Mexican-American NIDDM subjects. Diabetes 1991; 40: 334–337.Google Scholar
  43. 43.
    Feingold KR, Grunfeld C, Pang M, Doerrler W, Krauss RM. LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes. Arteriosclerosis Throm 1992; 12: 1496–1502.CrossRefGoogle Scholar
  44. 44.
    Bagdade JD, Buchanan WE, Kuusi T, Taskinen M. Persistent abnormalities in lipoprotein composition in noninsulin-dependent diabetes after intensive insulin therapy. Arteriosclerosis 1990; 10: 232–239.PubMedCrossRefGoogle Scholar
  45. 45.
    Taskinen M, Kuusi T, Helve E, Nikkila EA, Yki-Jarvinen H. Insulin therapy induces antiatherogenic changes of serum lipoproteins in noninsulin-dependent diabetes. Arteriosclerosis 1988; 8: 168–177.PubMedCrossRefGoogle Scholar
  46. 46.
    Stewart MW, Laker MF, Dyer RG, et al. Lipoprotein compositional abnormalities and insulin resistance in type II diabetic patients with mild hyperlipidemia. Arteriosclerosis Thromb 1993; 13: 1046–1052.CrossRefGoogle Scholar
  47. 47.
    Fielding CJ, Reaven GM, Liu G, Fielding PE. Increased free cholesterol in plasma low and very low density lipoproteins in non-insulin-dependent diabetes mellitus: its role in the inhibition of cholesteryl ester transfer. Proc Natl Acad Sci USA 1984; 81: 2512–2516.PubMedCrossRefGoogle Scholar
  48. 48.
    James RW, Pometta D. The distribution profiles of very low density and low density lipoproteins in poorly-controlled male type 2 diabetic patients. Diabetologia 1991; 34: 246–252.PubMedCrossRefGoogle Scholar
  49. 49.
    Hiramatsu K, Bierman EL, Chait A. Metabolism of low-density lipoprotein from patients with diabetic hypertriglyceridemia by cultured human skin fibroblasts. Diabetes 1985; 34: 8–14.PubMedCrossRefGoogle Scholar
  50. 50.
    Lopes-Virella MFL, Stone PG, Colwell JA. Serum high density lipoprotein in diabetic patients. Diabetologia 1977; 13: 285–291.PubMedCrossRefGoogle Scholar
  51. 51.
    Ahnadi C-E, Masmoudi T, Berthezene F, Ponsin G. Decreased ability of high density lipoproteins to transfer cholesterol esters in non-insulin-dependent diabetes mellitus. Eur J Clin Invest 1993; 23: 459–465.PubMedCrossRefGoogle Scholar
  52. 52.
    Taskinen MR, Beltz WF, Harper I, Fields RM, Grundy SM, Howard BV. Effects of NIDDM on very-low-density lipoprotein triglyceride and apoprotein B metabolism: studies before and after sulfonylurea therapy. Diabetes 1986; 35: 1268–1277.PubMedCrossRefGoogle Scholar
  53. 53.
    Haffner SM, Foster DM, Kushwaha RS, Hazzard WR: Retarded chylomicron apolipoprotein-B catabolism in type 2 diabetic subjects with lipemia. Diabetologia 1984; 26: 349–354.PubMedCrossRefGoogle Scholar
  54. 54.
    Ginsberg HN. VDL metabolism in diabetes mellitus. Diabetes/Metabolism Rev 1987; 3: 571–589.CrossRefGoogle Scholar
  55. 55.
    Biesbroeck RC, Albers JJ, Wahl PW, Weinberg CR, Bassett ML, Bierman EL. Abnormal composition of high density lipoproteins in non-insulin-dependent diabetics. Diabetes 1982; 31: 126–131.PubMedGoogle Scholar
  56. 56.
    Uusitupa MIJ, Niskanen LK, Siitonen O, Voutilainen E, Pyroalal K. Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type II diabetic and non-diabetic subjects. Diabetologia 1993; 36: 1175–1184.PubMedCrossRefGoogle Scholar
  57. 57.
    Tilly-Kiesi M, Syvanne M, Kuusi T, Landenpera S, Taskinen M. Abnormalities of low density lipoproteins in normolipidemic type II diabetic and nondiabetic patients with coronary artery disease. J Lipid Res 1992; 33: 333–342.PubMedGoogle Scholar
  58. 58.
    Krauss RM. Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk. Curr Opin Lipidol 1994; 5: 339–349.PubMedCrossRefGoogle Scholar
  59. 59.
    Haffner SM, Mykkanen L, Stern MP, Paidi M, Howard BV. Greater effect of diabetes on LDL size in women than in men. Diabetes Care 1994; 17: 1164–1170.PubMedCrossRefGoogle Scholar
  60. 60.
    Stern MP. Diabetes and cardiovascular disease: the “common soil” hypothesis. Diabetes 1995; 44: 369–374.PubMedCrossRefGoogle Scholar
  61. 61.
    McNamara JR, Jenner JL, Zhengling L, Wilson PWF, Schaefer EJ. Change in LDL particle size is associated with change in plasma triglyceride concentration. Arteriosclerosis Thromb 1992; 12: 1284–1290.CrossRefGoogle Scholar
  62. 62.
    Barakat HA, Carpenter JW, McLendon VD, et al. Influence of obesity, impaired glucose tolerance, and NIDDM on LDL structure and composition: possible link between hyperinsulinemia and atherosclerosis. Diabetes 1990; 39: 1527–1533.PubMedCrossRefGoogle Scholar
  63. 63.
    Campos H, Roederer GO, Lussier-Cacan S, Davignon J, Krauss RM. Predominance of large LDL and reduced HDL2 cholesterol in normolipidemic men with coronary artery disease. Arteriosclerosis Thromb Vasc Biol 1995; 15: 1043–1048.Google Scholar
  64. 64.
    Witztum JL, Mahoney EM, Branks MJ, Fisher M, Elam R, Steinberg D. Nonenzymatic glucosylation of low-density lipoprotein alters its biologic activity. Diabetes 1982; 31: 283–291.PubMedCrossRefGoogle Scholar
  65. 65.
    Steinbrecher JP, Witztum JL. Glucosylation of low-density lipoprotein to an extent comparable to that seen in diabetics slows their catabolism. Diabetes 1984; 33: 130–134.PubMedCrossRefGoogle Scholar
  66. 66.
    Reaven PD, Picard L, Witztum JL. Low-density lipoprotein metabolism in diabetes. In: Diabetes and Atherosclerosis. Draznin B, Eckel RH, eds. New York: Elsevier, pp. 17–38, 1993.Google Scholar
  67. 67.
    Calvo C, Luo B, Puygranier F, Ponsin G, Berthezene F. characterization and metabolism of glycated high-density lipoproteins in diabetic patients. Adv Exp Med Biol 1988; 243: 165–172.PubMedCrossRefGoogle Scholar
  68. 68.
    Kraemer FB, Chen Y, Lopez RD, Reaven GM. Effects of non-insulin-dependent diabetes on the uptake of VLDL by thioglycolate-elicited mouse peritoneal macrophages. JCEM 1985; 61: 335–342.PubMedGoogle Scholar
  69. 69.
    Duell PB, Oram JF, Bierman EL. Non-enzymatic glycosylation of HDL and impaired HDLreceptor-mediated cholesterol efflux. Diabetes 1991; 40: 377–384.PubMedCrossRefGoogle Scholar
  70. 70.
    Lyons TJ, Klein RL, Baynes JW, et al. Stimulation of cholesteryl ester synthesis in human monocyte-derived macrophages by low-density lipoproteins from type 1 diabetic patients: the influence of non-enzymatic glycosylation of low-density lipoproteins. Diabetologia 1987; 30: 916–923.PubMedCrossRefGoogle Scholar
  71. 71.
    Sobenin IA, Tertov VV, Koschinsky T, et al. Modified low-density lipoprotein from diabetic patients causes cholesterol accumulation in human intimal aortic cells. Atherosclerosis 1993; 100: 41–54.PubMedCrossRefGoogle Scholar
  72. 72.
    Chait A, Heinecke JW. Lipoprotein modification: cellular mechanisms. Curr Opin Lipidol 1994; 5: 365–370.PubMedCrossRefGoogle Scholar
  73. 73.
    Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–1607.PubMedCrossRefGoogle Scholar
  74. 74.
    Donahue RP, Orchard TJ. Diabetes mellitus and macrovascular complications. Diabetes Care 1992; 15: 1141–1155.PubMedCrossRefGoogle Scholar
  75. 75.
    Eschwege E, Balkau B, Fontbonne A. The epidemiology of coronary heart disease in glucose-intolerant and diabetic subjects. J Int Med 1994; 236: 5–11.Google Scholar
  76. 76.
    Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Cardiovascular risk factors in confirmed prediabetic individuals: does the clock for coronary heart disease start ticking before the onset of clinical diabetes? ’AMA 1990; 263: 2893–2898.CrossRefGoogle Scholar
  77. 77.
    Coppack SW, Jensen MD, Miles JM. In vivo regulation of lipolysis in humans. J Lipid Res 1994; 35: 177–193.PubMedGoogle Scholar
  78. 78.
    Amer P. Control of lipolysis and its relevance to development of obesity. Diabetes/Metab Rev 1988; 4: 507–515.CrossRefGoogle Scholar
  79. 79.
    Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1960; is 785–789.Google Scholar
  80. 80.
    Yki-Jarvinen H, Taskinen M. Interrelationships among insulin’s antilipolytic and glucoregulatory effects and plasma triglycerides in nondiabetic and diabetic patients with endogenous hypertriglyceridemia. Diabetes 1988; 37: 1271–1278.PubMedCrossRefGoogle Scholar
  81. 81.
    Reaven GM, Greenfield MS. Diabetic hypertriglyceridemia: evidence for three clinical syndromes. Diabetes 1981; 30: 66–75.PubMedGoogle Scholar
  82. 82.
    Howard BV, Reitman JS, Vasquez B, Zech L. Very-low-density lipoprotein triglyceride metabolism in non-insulin-dependent diabetes mellitus: relationship to plasma insulin and free fatty acids. Diabetes 1983; 32: 271–276.PubMedCrossRefGoogle Scholar
  83. 83.
    Boren J, Rustaeus S, Wettesten M, Andersson M, Wiklund A, Olofsson S. Influence of triacylglycerol biosynthesis rate on the assembly of apoB-containing lipoproteins in Hep G2 cells. Arteriosclerosis Thromb 1993; 13: 1743–1754.CrossRefGoogle Scholar
  84. 84.
    McKeigue PM, Lows A, Chen Y, Marmot MG, Reaven GM. Relation of plasma triglyceride and apolipoprotein B levels to insulin-mediated suppression of non-esterified fatty acids. Arteriosclerosis Thromb 1993; 13: 1187–1192.CrossRefGoogle Scholar
  85. 85.
    Egusa G, Beltz WF, Grundy SM, Howard BV. Influence of obesity on the metabolism of apolipoprotein B in humans. JCI 1988; 76: 596–603.CrossRefGoogle Scholar
  86. 86.
    Patsch W, Franz S, Schonfeld G. Role of insulin in lipoprotein secretion by cultured rat hepatocytes. JCI 1983; 71: 1161–1174.PubMedCrossRefGoogle Scholar
  87. 87.
    Eckel RH. Lipoprotein lipases and diabetes mellitus. In: Diabetes and Atherosclerosis. Draznin B, Eckel RH, eds. New York: Elsevier, pp. 77–102, 1993.Google Scholar
  88. 88.
    Kissebah AH, Alfarsi S, Evans DJ, Adams PW. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in non-insulin-dependent diabetes mellitus. Diabetes 1982; 31: 217–225.PubMedCrossRefGoogle Scholar
  89. 89.
    Deckelbaum RJ, Granoth E, Oschry Y, Rose L, Eisenberg S. Plasma triglyceride determines structure-composition in low and high density lipoproteins. Arteriosclerosis 1984; 4: 225–231.PubMedCrossRefGoogle Scholar
  90. 90.
    Griffin BA, Packard CJ. Metabolism of very low density and low density lipoprotein subclasses. Curr Opinion in Lipidology 1994; 5: 200–206.CrossRefGoogle Scholar
  91. 91.
    Havel RJ, Kane JP. Structure and metabolism of plasma lipoproteins. In: The Metabolic Basis of Inherited Disease. Scriver CR, Beaudet AL, Sly WS, Valle D, eds. New York: McGraw-Hill, pp. 1129–1138, 1989.Google Scholar
  92. 92.
    Hollenbeck CB, Chen YI, Greenfield MS, Lardinois CK, Reaven GM. Reduced plasma high density lipoprotein-cholesterol concentrations need not increase when hyperglycemia is controlled with insulin in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1985; 62: 605–608.CrossRefGoogle Scholar
  93. 93.
    Despres J, Ferland M, Moorjani S, et al. Role of hepatic-triglyceride lipase activity in the association between intra-abdominal fat and plasma HDL cholesterol in obese women. Arteriosclerosis 1989; 9: 485–492.PubMedCrossRefGoogle Scholar
  94. 94.
    Kasim SE, Tseng K, Jen K-LC, Khilnani S. Significance of hepatic triglyceride lipase activity in the regulation of serum high density lipoproteins in type II diabetes mellitus. J Clin Endocrinol Metab 1987; 65: 183–187.PubMedCrossRefGoogle Scholar
  95. 95.
    Campos H, Dreon DM, Krauss RM. Associations of hepatic and lipoprotein lipase activities with changes in dietary composition and low density lipoprotein subclasses. J Lipid Res 1995; 36: 462–472.PubMedGoogle Scholar
  96. 96.
    Wing RR, Koeske R, Epstein LH, Nowalk MP, Gooding W, Becker D. Long-term effects of modest weight loss in type II diabetic patients. Arch Intern Med 1987; 147: 1749–1753.PubMedCrossRefGoogle Scholar
  97. 97.
    Barakat HA, McLendon VD, Marks R, Pories W, Heath J, Carpenter JW. Influence of morbid obesity and non-insulin-dependent diabetes mellitus on high-density lipoprotein composition and subpopulation distribution. Metabolism 1992; 41: 37–41.PubMedCrossRefGoogle Scholar
  98. 98.
    Garg G, Bonanome A, Grundy SM, Zhang Z, Unger RH. Comparison of a high-carbohydrate diet with a high-monounsaturated-fat diet in patients with non-insulin-dependent diabetes mellitus. New Engl J Med 1988; 319: 829–834.PubMedCrossRefGoogle Scholar
  99. 99.
    Coulston AM, Hollenbeck CB, Swislock ALM, et al. Persistence of hypertriglyceridemic effect of low-fat high-carbohydrate diets in NIDDM patients. Diabetes Care 1989; 12: 94–99.PubMedCrossRefGoogle Scholar
  100. 100.
    Tremblay A, Buemann B. Exercise-training, macronutrient balance and body weight control. Int J Obes 1995; 19: 79–86.Google Scholar
  101. 101.
    Wu MS, Johnston P, Sheu WH, et al. Effect of metformin of carbohydrate and lipoprotein metabolism in NIDDM patients. Diabetes Care 1990; 13: 1–8.PubMedCrossRefGoogle Scholar
  102. 102.
    Jeppesen J, Zhou M, Chen Y-DI, Reaven GM. Effect of metformin on postprandial lipemia in patients with fairly to poorly controlled NIDDM. Diabetes Care 1994; 17: 1093–1099.PubMedCrossRefGoogle Scholar
  103. 103.
    Orchard TJ. Dyslipoproteinemia and diabetes. Endocrinol Metab Clin North Am 1990; 19: 361–380.Google Scholar
  104. 104.
    Frayn KN. Insulin resistance and lipid metabolism. Curr Opin Lipidol 1993; 4: 197–204.CrossRefGoogle Scholar
  105. 105.
    Schneider J, Erren T, Zofel P, Kaffarnik H. Metformin-induced changes in serum lipids, lipoproteins, and apoproteins in non-insulin-dependent diabetes mellitus. Atherosclerosis 1990; 82: 97–103.PubMedCrossRefGoogle Scholar
  106. 106.
    Nathan DM, Roussell A, Godine JE. Glyburide or insulin for metabolic control in non-insulindependent diabetes mellitus: a randomized, double-blind study. Ann Intern Med 1988; 108: 334–340.PubMedGoogle Scholar
  107. 107.
    Anonymous. University group diabetes program: a study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results. Diabetes 1970; 19: 785–837.Google Scholar
  108. 108.
    Vinik AI, Colwell JA. Effects of gemfibrozil on triglyceride levels in patients with NIDDM. Diabetes Care 1993; 16: 37–43.PubMedCrossRefGoogle Scholar
  109. 109.
    Landenpea S, Tilly-Kiesi M, Vuorinen-Markkola H, Kussi T, Taskinen M. Effects of gemfibrozil on low-density lipoprotein particle size, density distribution and composition in patients with type II diabetes. Diabetes Care 1993; 16: 584–592.CrossRefGoogle Scholar
  110. 110.
    Connor WE, Prince MJ, Ullmann D, et al. The hypotriglyceridemic effect of fish oil in adult-onset diabetes without adverse glucose control. Ann NY Acad Sci 1993; 337–340.Google Scholar
  111. 111.
    Garg A, Grundy SM. Gemfibrozil alone and in combination with lovastatin for treatment of hypertriglyceridemia in NIDDM. Diabetes 1989; 38: 364–372.PubMedCrossRefGoogle Scholar
  112. 112.
    Garg A, Grundy SM. Lovastatin for lowering cholesterol levels in non-insulin-dependent diabetes mellitus. New Engl J Med 1988; 318: 81–86.PubMedCrossRefGoogle Scholar
  113. 113.
    Casader M, Ruiu G, Gambino R, Alemanno N, Veglia F, Pagano G. Hypercholesterolemia in non-insulin-dependent diabetes mellitus: different effect of simvastatin on VLDL and LDL cholesterol levels. Atherosclerosis 1993; 99: 47–53.CrossRefGoogle Scholar
  114. 114.
    Garg A, Grundy SM. Cholestyramine therapy for dyslipidemia in NIDDM. Clin Res 1992; 40: 239–244.Google Scholar
  115. 115.
    Garg A, Grundy SM. Nicotinic acid as therapy for dyslipidemia in non-insulin-dependent diabetes mellitus. JAMA 1990; 264: 723–726.PubMedCrossRefGoogle Scholar
  116. 116.
    Expert Panel on Detection E, and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NECP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). JAMA 1993; 269: 3015–3023.CrossRefGoogle Scholar
  117. 117.
    Jeppesen J, Zhou M-Y, Chen Y-DI, Reaven GM. Effect of glipizide treatment on postprandial lipaemia in patients with NIDDM. Diabetologia 1994; 37: 781–787.PubMedCrossRefGoogle Scholar
  118. 118.
    Syvanne M, Vuorinen-Markkola H, Hilden H, Taskinen M. Gemfibrozil reduces postprandial lipemia in non-insulin-dependent diabetes mellitus. Arteriosclerosis Thromb 1993; 13: 286–295.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • Lisa A. Kosmiski
  • Robert H. Eckel

There are no affiliations available

Personalised recommendations